

Another Promising Path to No Immunosuppression
The UP421 The UP421 trial represents a pioneering Phase I study involving human participants, which is evaluating a novel immune-evasive...


All about Islet Cell
RGB-5088 is a novel treatment for Type 1 Diabetes currently under investigation. This innovative therapy focuses on islet cell...


Lantidra
Lantidra is the first FDA-approved allogeneic pancreatic islet cellular therapy designed for adults with type 1 diabetes (T1D) who...